62555-05-9 Usage
General Description
"Silane, [[1-(3-iodo-2-propenyl)-1-methylpentyl]oxy]trimethyl-, (E)-" is a complex organic chemical compound. It contains silane, which is a group that includes silicon and hydrogen. Silane, [[1-(3-iodo-2-propenyl)-1-methylpentyl]oxy]trimethyl-, (E)- also includes other chemical groups such as iodo, propenyl, methylpentyl, and trimethyl groups. The presence of these groups indicates that this substance is likely to be volatile and reactive. The (E)- prefix indicates the geometric configuration of the molecule, referring to the spatial arrangement of atomic groups around a double bond. The exact properties, uses, and hazards of this specific compound can vary greatly depending on its exact molecular structure and the conditions under which it is used or stored.
Check Digit Verification of cas no
The CAS Registry Mumber 62555-05-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,5,5 and 5 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 62555-05:
(7*6)+(6*2)+(5*5)+(4*5)+(3*5)+(2*0)+(1*5)=119
119 % 10 = 9
So 62555-05-9 is a valid CAS Registry Number.
62555-05-9Relevant articles and documents
An efficient synthesis of the antisecretory prostaglandin enisoprost
Dygos,Adamek,Babiak,Behling,Medich,Ng,Wieczorek
, p. 2549 - 2552 (2007/10/02)
-
1-Substituted-1-oxo-prostane-derivatives of the E, A and F series
-
, (2008/06/13)
The invention disclosed herein relates to pharmacologically active prostaglandin derivatives of the E, F, or A series having on the terminal methylene carbon of the alpha chain, a substituent selected from the group consisting of: STR1 wherein R is C1 to C6 alkyl, and phenyl or phenyl substituted with one or more substituents selected from the group consisting of C1 -C4 alkyl, OR16, SR16, F, or Cl, and R16 is C1 to C6 alkyl.
11-(2-Hydroxyethylthio) prostenoic acid E and F series derivatives
-
, (2008/06/13)
This disclosure describes certain 11-(2-hydroxyethylthio) prostenoic acid E and F series derivatives, and their intermediates, useful as bronchodilators and inflammatory medeator release inhibitors.